texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials

Share:

 
 

Texas Oncology-Fort Worth 8th Ave. Earns Accreditation

Facility is First in Tarrant County to Receive Distinction


FORT WORTH, Texas — Texas Oncology–Fort Worth 8th Ave. has been awarded a three-year term of accreditation in radiation oncology by the American College of Radiology (ACR). Notably, Texas Oncology–Fort Worth 8th Ave. is the first ACR-accredited facility in Tarrant County and is one of only three in North Texas.

The ACR seal of accreditation represents the highest level of quality and patient safety in radiation oncology. It is awarded only to facilities meeting specific practice guidelines and technical standards developed by ACR after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field.

“Texas Oncology–Fort Worth 8th Ave. is proud to join the distinguished list of ACR-accredited facilities,” said Dr. Jerry L. Barker, Jr., radiation oncologist at Texas Oncology–Fort Worth 8th Ave. “Our radiation oncologists have implemented an evidence-based approach to managing patients with leading-edge radiotherapy. This is rewarding recognition for our talented and dedicated physicians and healthcare team.”

Radiation oncology is the careful use of high-energy radiation to treat cancer. A radiation oncologist may use radiation to treat cancer or to relieve a cancer patient’s pain.

Texas Oncology –Fort Worth 8th Ave. provides leading-edge radiation technologies and treatments. As a pioneer in community-based cancer care, Texas Oncology provides leading-edge cancer care with advanced technologies in local communities where patients can stay near the critical support of family and friends. Patients have the opportunity to participate in some of the most promising national clinical trials, including radiation clinical trials, for a broad range of cancers. Texas Oncology, through its affiliation with US Oncology Research, has played a role in 50 FDA-approved cancer therapies, nearly one-third of all cancer therapies approved by the FDA to date.

The ACR is the nation’s oldest and most widely accepted radiation oncology accrediting body, with 27 years of accreditation experience. Patient care and treatment, patient safety, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs are assessed in its accrediting process.

The ACR is a national professional organization serving more than 36,000 diagnostic/interventional radiologists, radiation oncologists, nuclear medicine physicians, and medical physicists with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive health care services.
 


About Texas Oncology

As an independent oncology practice with more than 420 physicians and 175 locations, Texas Oncology’s community-based care offers patients high-quality cancer care without compromise, including access to leading-edge technology, advanced treatment options, and access to clinical trials. As a primary participant in US Oncology Research, Texas Oncology played a role in more than 70 FDA-approved therapies, about one-third of all cancer therapies approved by the agency to date.

Texas Center for Proton Therapy, Texas Breast Specialists, and Texas Center for Interventional Surgery are part of Texas Oncology. Texas Oncology is a member of The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks. For more information, visit www.TexasOncology.com.